| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Newton Charles W. is a Chief Financial Officer at Lyell Immunopharma, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $549K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Financial Officer | Sell | 1,453 | $10.54 | $15,320.43 | -8.7% | +61.7% | - | |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Financial Officer | Sell | 267 | $10.43 | $2,784.87 | -1.5% | +67.3% | - | |
| Mar 17, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Financial Officer | Buy | 200,000 | $0.56 | $111,620.00 | New | -1.7% | +94.7% |